Viemed Healthcare (VMD) Cash & Equivalents (2018 - 2026)

Viemed Healthcare's Cash & Equivalents history runs 9 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• Quarterly Cash & Equivalents fell 3.92% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 3.92% YoY) and the FY2025 annual result came in at $13.5 million, down 23.03% from the prior year.
• Cash & Equivalents was $9.8 million for Q1 2026 at Viemed Healthcare, down from $13.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $29.2 million in Q1 2022 and bottomed at $7.3 million in Q1 2024.
• A 5-year average of $15.0 million and a median of $12.8 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents sank 68.96% — and 2025, when it surged 127.27%.
• Viemed Healthcare's Cash & Equivalents stood at $16.9 million in 2022, then decreased by 24.09% to $12.8 million in 2023, then jumped by 36.62% to $17.5 million in 2024, then slipped by 23.03% to $13.5 million in 2025, then decreased by 27.69% to $9.8 million in 2026.
• Business Quant data shows VMD's Cash & Equivalents at $9.8 million in Q1 2026, $13.5 million in Q4 2025, and $11.1 million in Q3 2025.